Key result
Clinical thromboembolism risk factors in non-rheumatic AF strongly correlate with thrombogenic TOE markers.
Why the study?
The correlation between clinical risk factors for thromboembolism and transoesophageal echocardiography markers of a thrombogenic milieu in non-rheumatic atrial fibrillation required clarification.
Cross-Sectional (n=301)
No
Answers are grounded in this paper and cite their sources.
Demonstrates a strong link between clinical risk factors and echocardiographic clot markers in atrial fibrillation, indicating transoesophageal imaging identifies hidden risks.
OBJECTIVE: To correlate clinical risk factors for thromboembolism with transoesophageal echocardiography (TOE) markers of a thrombogenic milieu. DESIGN: Clinical risk factors for thromboembolism and TOE markers of a thrombogenic milieu were assessed in consecutive patients with non-rheumatic atrial fibrillation. The following TOE parameters were assessed: presence of spontaneous echo contrast, thrombi, and left atrial appendage blood flow velocities. A history of hypertension, diabetes mellitus, or thromboembolic events, patient age > 65 years, and chronic heart failure were considered to be clinical risk factors for thromboembolism. SETTING: Tertiary cardiac care centre. PATIENTS: 301 consecutive patients with non-rheumatic atrial fibrillation scheduled for TOE. RESULTS: 255 patients presented with clinical risk factors. 158 patients had reduced left atrial blood flow velocities, dense spontaneous echo contrast, or both. Logistic regression analysis showed that a reduced left ventricular ejection fraction and age > 65 years were the only independent predictors of a thrombogenic milieu (both p < 0.0001). The probability of having a thrombogenic milieu increased with the number of clinical risk factors present (p < 0.0001). 17.4% of the patients without clinical risk factors had a thrombogenic milieu whereas 41.2% of the patients presenting one or more clinical risk factors had none. CONCLUSION: There is a close relation between clinical risk factors and TOE markers of a thrombogenic milieu. In addition, TOE examination allows for the identification of patients with a thrombogenic milieu without clinical risk factors.
No takes yet. Share an insight, caveat, or question.
Stefan Illien (2003) conducted a cross-sectional in Non-rheumatic atrial fibrillation (n=301). Clinical risk factors for thromboembolism (hypertension, diabetes, prior thromboembolism, age > 65 years, chronic heart failure) vs. Absence of clinical risk factors for thromboembolism was evaluated on Transoesophageal echocardiography (TOE) markers of a thrombogenic milieu (reduced left atrial blood flow velocities, dense spontaneous echo contrast, or thrombi) (p=<0.0001). Clinical risk factors for thromboembolism in non-rheumatic AF strongly correlated with TOE markers of a thrombogenic milieu (p<0.0001), though 17.4% without risk factors also had markers.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: